Introducing Horizons ETFs’ Suite of Marijuana ETFs
1 Source: Cannabis producers could be chasing global market worth $194 billion in seven years: BMO report, November 1, 2018.
2 Source: North America Legal Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023, IMARC, 2018.
3 Source: Canada’s Legal Cannabis Market by the Numbers, BNN Bloomberg, June 20, 2018.
4 Source: Government of Canada, Health Canada, Authorized Licensed Producers of Cannabis for Medical Purposes, as at March 8, 2019.
5 Source: Legal Marijuana Market Worth $146.4 Billion by 2025, CARG: 34.6%, Grand View Research, April 2018.
* There are risks associated with this product. HMUS is expected to invest in the Marijuana industry in certain U.S. states that have legalized marijuana for therapeutic or adult-use, which is currently illegal under U.S. federal law. HMUS will passively invest in companies involved in the marijuana industry in the U.S. where local state law regulates and permits such activities, as well as in companies involved in the Canadian legal Marijuana industry. HMUS will not be directly engaged in the manufacture, importation, possession, use, sale or distribution of marijuana in either Canada or the U.S. Please read the full risk disclosure in the prospectus before investing.
Share This Article
Webinar: Cannabis Industry Investing Outlook
Tune into this 45-minute webinar featuring Steve Hawkins, President and CEO of Horizons ETFs, as he discusses potential growth opportunities in the ever-evolving marijuana industry. Click here to watch now.
Subscribe for Marijuana Updates
© 2021 Horizons ETFs Management (Canada) Inc. All rights reserved.
© 2021 Horizons ETFs Management (Canada) Inc. All rights reserved.
Commissions, management fees and expenses all may be associated with an investment in exchange traded products managed by Horizons ETFs Management (Canada) Inc. (the “Horizons Exchange Traded Products”). The Horizons Exchange Traded Products are not guaranteed, their value changes frequently and past performance may not be repeated. Certain ETFs may have exposure to leveraged investment techniques that magnify gains and losses and which may result in greater volatility in value and could be subject to aggressive investment risk and price volatility risk. Such risks are described in the prospectus. The prospectus contains important detailed information about the ETF. Please read the relevant prospectus before investing.
The Horizons Exchange Traded Products include our BetaPro products (the “BetaPro Products”). The BetaPro Products are alternative mutual funds within the meaning of National Instrument 81-102 Investment Funds, and are permitted to use strategies generally prohibited by conventional mutual funds: the ability to invest more than 10% of their net asset value in securities of a single issuer, to employ leverage, and engage in short selling to a greater extent than is permitted in conventional mutual funds. While these strategies will only be used in accordance with the investment objectives and strategies of the BetaPro Products, during certain market conditions they may accelerate the risk that an investment in shares of a BetaPro Product decreases in value. The BetaPro Products consist of our Daily Bull and Daily Bear ETFs (“Leveraged and Inverse Leveraged ETFs”), Inverse ETFs (“Inverse ETFs”) and our BetaPro S&P 500 VIX Short-Term Futures™ ETF (the “VIX ETF”). Included in the Leveraged and Inverse Leveraged ETFs and the Inverse ETFs are the BetaPro Marijuana Companies 2x Daily Bull ETF (“HMJU”) and BetaPro Marijuana Companies Inverse ETF (“HMJI”), which track the North American MOC Marijuana Index (NTR) and North American MOC Marijuana Index (TR), respectively. The Leveraged and Inverse Leveraged ETFs and certain other BetaPro Products use leveraged investment techniques that can magnify gains and losses and may result in greater volatility of returns. These BetaPro Products are subject to leverage risk and may be subject to aggressive investment risk and price volatility risk, among other risks, which are described in their respective prospectuses. Each Leveraged and Inverse Leveraged ETF seeks a return, before fees and expenses, that is either up to, or equal to, either 200% or –200% of the performance of a specified underlying index, commodity futures index or benchmark (the “Target”) for a single day. Each Inverse ETF seeks a return that is –100% of the performance of its Target. Due to the compounding of daily returns a Leveraged and Inverse Leveraged ETF’s or Inverse ETF’s returns over periods other than one day will likely differ in amount and, particularly in the case of the Leveraged and Inverse Leveraged ETFs, possibly direction from the performance of their respective Target(s) for the same period. For certain Leveraged and Inverse Leveraged ETFs that seek up to 200% or up to or -200% leveraged exposure, the Manager anticipates, under normal market conditions, managing the leverage ratio as close to two times (200%) as practicable however, the Manager may, at its sole discretion, change the leverage ratio based on its assessment of the current market conditions and negotiations with the respective ETF’s counterparties at that time. Hedging costs charged to BetaPro Products reduce the value of the forward price payable to that ETF. Due to the high cost of borrowing the securities of marijuana companies in particular, the hedging costs charged to HMJI are expected to be material and are expected to materially reduce the returns of HMJI to unitholders and materially impair the ability of HMJI to meet its investment objectives. Currently, the manager expects the hedging costs to be charged to HMJI and borne by unitholders will be between 10.00% and 45.00% per annum of the aggregate notional exposure of HMJI’s forward documents. The hedging costs may increase above this range. The manager publishes on its website, the updated monthly fixed hedging cost for HMJI for the upcoming month as negotiated with the counterparty to the forward documents, based on the then current market conditions. The VIX ETF, which is a 1x ETF, as described in the prospectus, is a speculative investment tool that is not a conventional investment. The VIX ETF’s Target is highly volatile. As a result, the VIX ETF is not intended as a stand-alone long-term investment. Historically, the VIX ETF’s Target has tended to revert to a historical mean. As a result, the performance of the VIX ETF’s Target is expected to be negative over the longer term and neither the VIX ETF nor its target is expected to have positive long-term performance. BetaPro Bitcoin ETF (“HBIT”), and BetaPro Inverse Bitcoin ETF (“BITI”), which are a 1X ETF, and an up to -1X ETF, respectively, as described in the prospectus, are speculative investment tools that are not conventional investments. Their Target, an index which replicates exposure to rolling Bitcoin Futures and not the spot price of Bitcoin, is highly volatile. As a result, neither ETF is intended as a stand-alone investment. There are inherent risks associated with products linked to crypto-assets, including Bitcoin Futures. While Bitcoin Futures are traded on a regulated exchange and cleared by regulated central counterparties, direct or indirect exposure to the high level of risk of Bitcoin Futures will not be suitable for all types of investors. An investment in any of the BetaPro Products is not intended as a complete investment program and is appropriate only for investors who have the capacity to absorb a loss of some or all of their investment. Please read the full risk disclosure in the prospectus before investing. Investors should monitor their holdings in BetaPro Products and their performance at least as frequently as daily to ensure such investment(s) remain consistent with their investment strategies.
Horizons Total Return Index ETFs (“Horizons TRI ETFs”) are generally index-tracking ETFs that use an innovative investment structure known as a Total Return Swap to deliver index returns in a low-cost and tax-efficient manner. Unlike a physical replication ETF that typically purchases the securities found in the relevant index in the same proportions as the index, most Horizons TRI ETFs use a synthetic structure that never buys the securities of an index directly. Instead, the ETF receives the total return of the index through entering into a Total Return Swap agreement with one or more counterparties, typically large financial institutions, which will provide the ETF with the total return of the index in exchange for the interest earned on the cash held by the ETF. Any distributions which are paid by the index constituents are reflected automatically in the net asset value (NAV) of the ETF. As a result, the Horizons TRI ETF receives the total return of the index (before fees), which is reflected in the ETF’s share price, and investors are not expected to receive any taxable distributions. Certain Horizons TRI ETFs (Horizons Nasdaq-100 ® Index ETF and Horizons US Large Cap Index ETF) use physical replication instead of a total return swap. The Horizons Cash Maximizer ETF and Horizons USD Cash Maximizer ETF use cash accounts and do not track an index but rather a compounding rate of interest paid on the cash deposits that can change over time.
*The indicated rates of return are the historical annual compounded total returns including changes in per unit value and reinvestment of all dividends or distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The rates of return shown in the table are not intended to reflect future values of the ETF or returns on investment in the ETF. Only the returns for periods of one year or greater are annualized returns.
The financial instrument is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Index and/or Index trade name or the Index Price at any time or in any other respect. The Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards the Issuer, Solactive AG has no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the financial instrument. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trade name for the purpose of use in connection with the financial instrument constitutes a recommendation by Solactive AG to invest capital in said financial instrument nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in this financial instrument.
“Standard & Poor’s®” and “S&P®” are registered trademarks of Standard and Poor’s® Financial Services LLC (“S&P”), “TSX®” is a registered trademark of TSX Inc.(“TSX”), and Morningstar® is a registered trademark of Morningstar Research Inc. (“Morningstar”). These marks have been licensed for use by Horizons ETFs Management (Canada) Inc. where applicable. The Horizons Exchange Traded Products are not sponsored, endorsed, sold, or promoted by S&P, TSX, or Morningstar and their affiliated companies and none of these parties make any representation, warranty or condition regarding the advisability of buying, selling or holding units/shares in the Horizons Exchange Traded Products. All trademarks/service marks are registered by their respective owners. None of the owners thereof or any of their affiliates sponsor, endorse, sell, promote or make any representation regarding the advisability of investing in the Horizons Exchange Traded Products.
The mark and name “Hang Seng High Dividend Yield Index” (the “Index”) is proprietary to Hang Seng Data Services Limited (“HSDS”) which has licensed its compilation and publication to Hang Seng Indexes Company Limited (“HSIL”). HSIL and HSDS have agreed to the use of, and reference to, the Index by Horizons ETFs Management (Canada) Inc. (“the Issuer”) in connection with the Horizons China High Dividend Yield Index ETF (the “Product”). However, neither HSIL nor HSDS warrants, represents or guarantees to any person the accuracy or completeness of the Index, its computation or any information related thereto and no warranty, representation or guarantee of any kind whatsoever relating to the Index is given or may be implied. Neither HSIL nor HSDS accepts any responsibility or liability for any economic or other loss which may be directly or indirectly sustained by any person as a result of or in connection with the use of and/or reference to the Index by the Issuer in connection with the Product, or any inaccuracies, omissions or errors of HSIL in computing the Index. Any person dealing with the Product shall place no reliance whatsoever on HSIL and/or HSDS nor bring any claims or legal proceedings against HSIL and/or HSDS in any manner whatsoever. For the avoidance of doubt, this disclaimer does not create any contractual or quasi-contractual relationship between any broker or other person dealing with the Product and HSIL and/or HSDS and must not be construed to have created such relationship. Click here to read more
Horizons ETFs is committed to providing a respectful, welcoming and accessible environment for all persons with disabilities; treating all individuals in a way that allows them to maintain their dignity and independence. We are devoted to offering our services in a manner that is accessible to all clients.
We believe in integration and equal opportunity, which is why we are committed to a workplace that is accessible and enables our employees to participate fully. Our policies are designed to keep the recruitment, retention and development of talent impartial and barrier-free. Every employee is expected to contribute to creating and sustaining such a workplace. Horizons ETFs ensures that all individuals are aware of their rights and responsibilities to promote an accessible working environment for persons with disabilities.
Upon request, Horizons ETFs will provide a copy of the policy for those individuals requesting it, in accessible format that takes into account the person’s disability, if any. We welcome and appreciate feedback regarding this policy. To obtain a copy of the policy or to comment on its content, please contact our Human Resources department and the email provided below.
Mail: Horizons ETFs Management (Canada) Inc.
Attn: Human Resources Department
55 University Avenue, Suite 800
Toronto, Ontario, M5J 2H7
Best Marijuana ETFs for Q2 2022
YOLO, MJ, and MSOS are the best marijuana ETFs for Q2 2022
Charles is an award-winning writer and marketing communications professional with over a decade of experience in journalism covering finance, business, real estate, and marketing. A recognized expert in his field, Charles’ insights have appeared in major national publications including Investopedia.
Marijuana exchange-traded funds (ETFs) provide investors with exposure to equities of companies that engage in the cultivation, distribution, and sale of marijuana and related products. Products of marijuana companies include dried flowers, oils, seeds, edibles, and more.
Still prohibited as an illegal substance in many parts of the world, marijuana is gaining wider acceptance for both medicinal and recreational purposes. Support for continued legalization is growing, and cannabis is now a multibillion-dollar industry. The global legal marijuana market is expected to expand at a healthy compound annual growth rate (CAGR) of 26.7% through 2028. Marijuana ETFs are a straightforward way for investors to gain exposure to a diversified basket of marijuana equities and profit from this growing industry.
- Marijuana equities have significantly underperformed the broader U.S. equity market over the past year.
- The marijuana exchange-traded funds (ETFs) with the best one-year trailing total returns are YOLO, MJ, and MSOS.
- The top holdings these funds is the AdvisorShares Pure US Cannabis ETF, Tilray Brands Inc., and Innovative Industrial Properties Inc., respectively.
Six marijuana ETFs trade in the United States, excluding inverse and leveraged ETFs as well as funds with less than $50 million in assets under management (AUM). The marijuana sector, as measured by the Global Cannabis Stock Index, has dramatically underperformed the broader U.S. stock market over the past 12 months, with a 1-year price change of -60.7% compared to the S&P 500’s 1-year trailing total return of 14.9% as of March 2, 2022. The best-performing marijuana ETF, based on performance over the past year, is the AdvisorShares Pure Cannabis ETF (YOLO).
We examine the three best marijuana ETFs below. All numbers below are as of March 6, 2022.
AdvisorShares Pure Cannabis ETF (YOLO)
- Performance Over One-Year: -58.3%
- Expense Ratio: 0.76%
- Annual Dividend Yield: 0.22%
- Three-Month Average Daily Volume: 119,602
- Assets Under Management: $142.7 million
- Inception Date: April 17, 2019
- Issuer: AdvisorShares
YOLO is an actively managed ETF that seeks long-term capital appreciation by investing in both domestic and foreign cannabis equities. It invests in small and mid-cap global companies that derive at least 50% of their revenue from the marijuana and hemp industry. Companies must be approved by the U.S. Drug Enforcement Administration (DEA) to use marijuana for legal research and the development of cannabis or cannabinoid-related products.
YOLO is designed to take advantage of the cannabis industry’s long-term growth and may be ideal for a buy-and-hold portfolio. It also allocates at least 25% of its portfolio to biotechnology, pharmaceuticals, and life sciences companies. The fund’s top three holdings are AdvisorShares Pure US Cannabis ETF (MSOS), which accounts for 35.3% of the portfolio; Innovative Industrial Properties Inc. (IIPR), a real estate investment trust (REIT) focused on the cannabis industry; and Village Farms International Inc. (VFF:TSE), a Canada-based grower of tomatoes, bell peppers, cucumbers, and cannabis.
ETFMG Alternative Harvest ETF (MJ)
- Performance Over One-Year: -58.4%
- Expense Ratio: 0.75%
- Annual Dividend Yield: 1.56%
- Three-Month Average Daily Volume: 1,277,663
- Assets Under Management: $660.0 million
- Inception Date: Dec. 2, 2015
- Issuer: ETFMG
MJ is the first ETF to focus on the global cannabis industry and tracks the Prime Alternative Harvest Index. The gauge tracks the performance of companies within the global cannabis industry that area benefiting from the growth, marketing, and sale of cannabis products for medicinal and recreational use. Like other cannabis ETFs, investors should note that the fund’s large number of thinly-traded small-cap stocks raises the issue of whether there might be sufficient liquidity to absorb money flows without distorting prices. Since marijuana is still illegal under federal law in the U.S., MJ’s portfolio is dominated by Canadian cannabis companies.
The fund’s top three holdings are Tilray Brands Inc. (TLRY), a Canada-based provider of medical cannabis; Canopy Growth Corp. (WEED: TSE), a Canadian-based medical marijuana producer; and Sundial Growers Inc. (SNDL), a Canadian-based cannabis company.
AdvisorShares Pure US Cannabis ETF (MSOS)
- Performance Over One-Year: -59.3%
- Expense Ratio: 0.73%
- Annual Dividend Yield: N/A
- Three-Month Average Daily Volume: 1,608,831
- Assets Under Management: $1.0 billion
- Inception Date: Sept. 1, 2020
- Issuer: AdvisorShares
MSOS is an actively managed fund that focuses on owning U.S. cannabis companies, including multi-state operators (MSOs), that are involved in diverse parts of the industry. The ETF seeks long-term capital appreciation. Like YOLO, the companies in MSOS’s portfolio must be registered with the DEA for dealing with marijuana for lawful research and the development of cannabis or cannabinoid-related products. The ETF’s holdings may focus on areas like REITs, healthcare, hydroponics, and pharmaceuticals.
MSOS also uses swap contracts to provide exposure to the cannabis sector, which may increase volatility. The fund’s top three stock holdings are Innovative Industrial Properties Inc., described above; GrowGeneration Corp. (GRWG), a hydroponic and organic specialty gardening products retailer; and Hydrofarm Holdings Group, Inc. (HYFM), which manufactures and distributes controlled environment agriculture equipment and supplies.
The comments, opinions, and analyses expressed herein are for informational purposes only and should not be considered individual investment advice or recommendations to invest in any security or adopt any investment strategy. While we believe the information provided herein is reliable, we do not warrant its accuracy or completeness. The views and strategies described in our content may not be suitable for all investors. Because market and economic conditions are subject to rapid change, all comments, opinions, and analyses contained within our content are rendered as of the date of the posting and may change without notice. The material is not intended as a complete analysis of every material fact regarding any country, region, market, industry, investment, or strategy.